Loading data for TWST — first visit, this takes a few seconds.

アラート

Twist Bioscience Corporat... (TWST)

NasdaqGS: TWST · リアルタイム株価 · USD

145.59

+9.26 (6.79%)

終値時点： Aug 21, 2026, 8:00 PM

145.90

+0.21%

寄り付き前: 8:59 AM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

6.79% (1D)

データがありません

買気配	102.9
時価総額	9.13B
売上高（TTM）	431.8M
純利益（TTM）	-136.72M
	2.16
	-2.23
	n/a
	-229.88
PBR（TTM）	20.47
PSR（TTM）	21.14
決算発表日	Nov 16, 2026

売気配	174.89
出来高	1,795,556
平均出来高（20日）	1,808,412
始値	138.80
前日終値	136.33
当日レンジ	135.11 - 145.93
52週レンジ	23.30 - 145.93
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

TWSTについて

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mu...

[続きを読む]

業種 Diagnostics & Research

セクター Healthcare

IPO日 Oct 31, 2018

従業員数 979

上場取引所 NasdaqGS

ティッカー TWST

ウェブサイト https://www.twistbioscience.com

企業情報の全文

業績

2025年のTwist Bioscienceの売上高は376.57Mで、前年の312.97Mから20.32%の増加でした。利益は-77.67Mで、-62.79%の減少でした。

財務諸表

決算サプライズ

Twist BioscienceはAug 3, 2026に四半期決算を発表しました：

売上高は $118.38M で、予想を下回りました $0, うち 23.24% の前年比増加にあたります.
EPSは -0.56 で、予想を下回りました -0.38, うち -19.15% の前年比減少.

次回決算発表

Twist Bioscience Corporationの決算発表予定日は Nov 16, 2026, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

5日前 · MT Newswires

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index rising 3.1% a

5日前 · Stocktwits

‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’

Claude-designed proteins successfully bound to 14 of 15 targets in independent testing by Adaptyv Bio and Twist Bioscience.

1週間前 · 24/7 Wall St.

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)

Anthropic is racing toward a public debut in September with a healthcare AI pitch that could ignite a sector most investors are not watching. Five biotech names are already moving, and one has climbed...

1週間前 · Motley Fool

Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript

AI-enabled drug discovery orders drive triple-digit growth as guidance rises.

2週間前 · Simply Wall St.

Twist Bioscience (TWST) Is Up 26.3% After Capital Raise And Guidance Hike Amid Legal Settlement Talks - Has The Bull Case Changed?

In early August 2026, Twist Bioscience completed a US$300 million follow-on common stock offering at US$96 per share after raising its fiscal 2026 revenue guidance to US$456 million–US$457 million and...

2ページ中1ページ